Repligen

RGEN

Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symb …

Insider trades and stock quote 2022-2024

All insider trades at Repligen

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
3/11/2024 SellKuriyel, Ralf Senior VP, R&D $193.7 $681,348
3/8/2024 SellHunt, Anthony Chief Executive Officer $199.0 $3,298,634
2/27/2024 SellDawes, Karen A. Director $193.4 $193,350
2/23/2024 SellBylund, James Chief Operating Officer $198.1 $866,204
11/10/2023 SellGebski, Christine Officer $147.1 $557,328
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)